Stay updated on Pembrolizumab in Esophagogastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Esophagogastric Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added in the revision history and Revision: v3.4.2 was removed. No impact on the study’s data or page usability.
    Difference
    0.1%
    Check dated 2026-03-12T21:30:32.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.1 to v3.4.2; a minor version change with no impact on study content or usability. - To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:02:14.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Footer revision updated to v3.4.1, replacing v3.4.0; this is a minor metadata change that does not affect study content or page interactions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T00:31:07.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added a glossary display option and updated study metadata to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T21:53:00.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4. This appears to be a minor back-end/formatting change and does not modify the study details or content presented on the page.
    Difference
    0.1%
    Check dated 2026-01-14T04:12:47.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Footer now includes Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2. This update does not affect study details or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T21:14:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Esophagogastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.